Manuel B. Garcia

Manuel B. Garcia serves as the Senior Director for Educational Technology and Digital Learning at FEU Institute of Technology, Manila, Philippines. Read More

Contact Info

1607, FEU Tech Building,
P. Paredes St, Sampaloc,
Manila, Philippines
mbgarcia@feutech.edu.ph

Follow Me

The Complete Library

All Research Guides

Browse every published guide in the Researcher's Field Guide, including the complete research journey and supplemental collections, listed alphabetically for quick reference.

Complete Library

Every published guide

Showing 1,401–1,450 of 5,065 guides

5,065 guides
PART 05 · SUBPART 24 · GUIDE 422

Can Researchers Stop When They Feel Unsafe?

Can Researchers End an Interview or Field Visit Because They Feel Unsafe?

Researchers do not have to complete an interview or field visit when they reasonably believe continuing could compromise their safety. The priority is to disengage safely, then report and reassess the incident appropriately.

PART 05 · SUBPART 24 · GUIDE 419

Who Is Responsible for Researcher Safety?

Who Is Responsible for Assessing and Managing Researcher Safety?

Researcher safety is rarely the responsibility of one person or committee. Researchers, principal investigators, supervisors, institutions, and ethics committees have different but overlapping roles in identifying and managing risk.

PART 05 · SUBPART 24 · GUIDE 417

Does Research Ethics Protect Researchers Too?

Does Research Ethics Protect Researchers as Well as Participants?

Research ethics is not concerned only with protecting participants. Ethical research also requires foreseeable risks to researchers and research teams to be identified, minimized, and appropriately managed.

PART 05 · SUBPART 23 · GUIDE 416

Researcher Responsibilities After a Project Ends

What Do Researchers Owe a Community After an International Research Project Ends?

A researcher's ethical responsibilities do not necessarily disappear when data collection or grant funding ends. International projects should plan for findings, data and samples, post-trial arrangements, partnerships, and an appropriate transition or exit.

PART 05 · SUBPART 23 · GUIDE 415

Returning Research Findings to Communities

Should Research Findings Be Returned to the Communities Where the Data Were Collected?

Researchers should generally plan to return meaningful findings to communities that contributed to the research, but returning results requires more than sending a journal article. What should be returned, to whom, and how depends on the study and the implications of the findings.

PART 05 · SUBPART 23 · GUIDE 414

Control of Data and Samples in International Research

Who Should Control Data and Samples Collected Through International Research?

No single party should automatically control data or samples simply because it funded, collected, stores, or analyzes them. International research needs explicit governance covering access, custody, secondary use, sharing, withdrawal, and future decision-making.

PART 05 · SUBPART 23 · GUIDE 412

Exploitative International Research Collaboration

What Makes International Research Collaboration Exploitative?

International collaboration becomes exploitative when one partner or community bears disproportionate burdens while others capture control, credit, resources, or benefits. Ethics approval and participant consent do not by themselves make an unequal partnership fair.

PART 05 · SUBPART 23 · GUIDE 411

When Community Engagement Becomes Tokenism

When Does Community Engagement Become Tokenism?

Community engagement becomes tokenistic when people are visibly included but have little meaningful opportunity to influence decisions relevant to their participation. Attendance, consultation, or representation alone does not establish genuine engagement.

PART 05 · SUBPART 23 · GUIDE 408

When Community Leaders Object to Participation

What Should You Do When Individual Participants Want to Participate but Community Leaders Object?

An individual’s willingness to participate does not automatically resolve a community objection. Researchers must determine whether leaders have legitimate authority over the research activity or collective interests involved, rather than assuming either individual consent or community opposition always prevails.

PART 05 · SUBPART 23 · GUIDE 406

Who Can Speak for a Community in Research?

Who Has the Authority to Speak for a Community in Research?

A chief, elder, elected official, organization, or advisory group may legitimately speak for some community interests, but authority is rarely unlimited. Researchers need to establish who is represented, what authority exists, and whose voices remain unheard.

PART 05 · SUBPART 23 · GUIDE 405

Community Consent and Individual Consent

What Is Community Consent, and When Does Research Need More Than Individual Consent?

Some research affects communities as well as individual participants, making community permission or consultation ethically important. Community approval, however, usually serves a different purpose from individual informed consent and should not be confused with it.

PART 05 · SUBPART 23 · GUIDE 401

When Ethics Requirements Differ Between Countries

What Should You Do When Ethics Requirements Differ Between Countries?

When countries impose different research ethics requirements, researchers should identify what each requirement governs rather than simply choosing the easier rule. Differences should be reconciled with the responsible ethics bodies while preserving appropriate participant protections.

PART 05 · SUBPART 23 · GUIDE 400

When International Research Needs Multiple Ethics Reviews

When Does International Research Need Ethics Review in More Than One Country?

International research may require ethics review in more than one country when responsibility for participants, research sites, institutions, or sponsorship crosses national boundaries. The required pathway depends on the research and the applicable oversight systems.

PART 05 · SUBPART 22 · GUIDE 397

When Confidentiality Has Limits

When Does Confidentiality Give Way to a Duty to Act or Report?

Research confidentiality is a substantive obligation, but it is not always absolute. Disclosure may be required or permitted by specific laws, safety duties, participant consent, or other governing rules, and those limits should be identified before sensitive data are collected.

PART 05 · SUBPART 22 · GUIDE 396

Discovering Possible Illegal Activity

What Should Researchers Do When They Discover Possible Illegal Activity?

Discovering possible illegal activity does not automatically require researchers to report it. Researchers should protect confidentiality, determine whether a specific legal or safety obligation applies, and follow the approved protocol rather than becoming investigators or informants by default.

PART 05 · SUBPART 22 · GUIDE 395

When a Participant May Harm Someone Else

What Should Researchers Do When a Participant Appears to Pose a Serious Risk to Someone Else?

A participant's threatening statement does not automatically create the same legal duty everywhere. Researchers should assess immediate safety through the study's approved procedure, involve qualified professionals, and determine the applicable confidentiality and duty-to-protect rules for their jurisdiction and professional roles.

PART 05 · SUBPART 22 · GUIDE 394

Self-Harm or Suicide Risk in Research

What Should Researchers Do When a Participant Discloses Self-Harm or Suicide Risk?

A disclosure of self-harm or suicidal thoughts should trigger the study's predefined safety process, not an improvised clinical judgment. Researchers should distinguish a positive research response from an assessed acute risk and escalate according to the participant's circumstances and the study protocol.

PART 05 · SUBPART 22 · GUIDE 393

When a Participant Discloses Abuse

What Should Researchers Do When a Participant Discloses Possible Abuse?

When a participant discloses possible abuse, researchers should respond calmly, assess immediate safety, avoid conducting their own investigation, and follow the study's safeguarding and reporting procedures. Whether disclosure must be reported depends on the participant, researcher, jurisdiction, and applicable law.

PART 05 · SUBPART 22 · GUIDE 392

Who Pays After an Incidental Finding?

Who Pays for Confirmatory Testing or Follow-Up After an Incidental Finding?

There is no universal rule making either researchers or participants responsible for every cost after an incidental finding. The answer depends on whether the expense is part of validating the research finding, communicating it responsibly, or subsequent clinical care, as well as the study's funding and governing policies.

PART 05 · SUBPART 22 · GUIDE 391

Communicating Incidental Findings

Who Should Explain an Incidental Finding to the Participant?

The person who discovers an incidental finding is not necessarily the right person to explain it. Communication should involve someone qualified to interpret the finding, explain its uncertainty and implications, and guide the participant toward appropriate follow-up.

PART 05 · SUBPART 22 · GUIDE 389

Choosing Whether to Receive Incidental Findings

Should Participants Be Allowed to Choose Whether They Want to Receive Incidental Findings?

Participants should generally be informed about foreseeable incidental findings and given meaningful choices about receiving qualifying information when the research can support those choices. The options, however, should be defined clearly rather than reduced to an unexplained “tell me everything” checkbox.

PART 05 · SUBPART 22 · GUIDE 388

Findings Affecting Health or Safety

What if a Research Finding Might Affect a Participant’s Health or Safety?

A finding that may affect a participant’s health or safety can require more than an ordinary return-of-results decision. Researchers should assess its reliability, seriousness, and urgency, then use the study’s approved safety, ethics, and referral procedures.

PART 05 · SUBPART 22 · GUIDE 387

Uncertain Incidental Findings

What if an Incidental Finding Is Potentially Important but Highly Uncertain?

A potentially serious but uncertain incidental finding should not automatically be disclosed or ignored. Researchers should identify the source of uncertainty, seek appropriate validation or expert review, and distinguish a finding that warrants further evaluation from one that is ready to return.

PART 05 · SUBPART 22 · GUIDE 386

Must Incidental Findings Be Actionable?

Does an Incidental Finding Need to Be Clinically Actionable Before It Should Be Returned?

Clinical actionability creates one of the strongest arguments for returning an incidental finding, but it is not universally treated as an absolute requirement. Some valid findings may have reproductive, personal, or other meaningful utility even when no treatment or prevention is available.

PART 05 · SUBPART 22 · GUIDE 385

When Is an Incidental Finding Returnable?

What Makes an Incidental Finding Important Enough to Return to a Participant?

No single characteristic makes an incidental finding important enough to return. The strongest cases usually combine reliable evidence, substantial significance, meaningful potential benefit, and consistency with the participant's preferences and the approved research plan.

PART 05 · SUBPART 22 · GUIDE 384

Disclosing Unexpected Findings

Should Researchers Tell Participants About Unexpected Findings?

Researchers should not automatically disclose every unexpected finding, nor automatically withhold one because it falls outside the study. Disclosure depends on the finding's reliability, significance, potential benefit and harm, participant preferences, and the approved research plan.

PART 05 · SUBPART 22 · GUIDE 383

Should Researchers Search for Secondary Findings?

Should Researchers Actively Look for Findings That Are Outside the Research Question?

A responsibility to manage an important finding that researchers happen to discover does not automatically create a responsibility to search for unrelated findings. Deliberate searching may be justified in some settings, but it changes the ethical and practical commitments of the research.

PART 05 · SUBPART 22 · GUIDE 382

Incidental vs. Secondary Findings

Incidental vs. Secondary Findings: What’s the Difference?

Incidental and secondary findings both fall outside the primary research question, but they differ in how they are discovered. Incidental findings are encountered without deliberately searching for them, while secondary findings are intentionally sought outside the study's primary aim.

PART 05 · SUBPART 21 · GUIDE 380

Indefinite Storage of Research Data and Samples

Can Research Data or Biological Samples Be Kept Indefinitely for Future Research?

Research data and biological samples can sometimes be stored indefinitely, but indefinite retention is not universally permissible. Consent, research purpose, legal requirements, identifiability, governance, security, scientific value, and a defensible retention rationale all matter.

PART 05 · SUBPART 21 · GUIDE 379

Withdrawal From a Biobank or Data Repository

What Happens When a Participant Withdraws From a Biobank or Long-Term Data Repository?

Withdrawal from a biobank or long-term repository usually stops specified future uses or collection rather than erasing every past use. What remains depends on the consent, repository design, identifiability, prior distribution, completed research, and applicable law.

PART 05 · SUBPART 21 · GUIDE 378

Withdrawing Samples After Analysis

Can Participants Withdraw Biological Samples After Analyses Have Already Been Performed?

Participants may be able to withdraw remaining identifiable biological samples from future research, but withdrawal cannot necessarily reverse analyses, recover distributed specimens, or erase findings already generated. These limits should be explained before specimens are stored.

PART 05 · SUBPART 21 · GUIDE 377

Who Owns Stored Biological Samples?

Who Owns Stored Biological Samples and the Information Derived From Them?

There is no universal rule that the person who supplied a biological sample, the researcher who collected it, or the institution storing it owns everything associated with it. Ownership, custody, control, consent rights, derived data, intellectual property, and commercial interests are distinct questions that depend heavily on law and agreements.

PART 05 · SUBPART 21 · GUIDE 376

Using Stored Samples for Unanticipated Research

Can Stored Biological Samples Be Used for Research the Donor Never Anticipated?

A donor does not necessarily have to have anticipated the exact future study for stored biological samples to be reused. The critical questions are whether the new research falls within the authorization or another permissible pathway, how identifiable the specimen is, and whether new methods create materially different risks or implications.

PART 05 · SUBPART 21 · GUIDE 375

Ethics of Secondary Use of Biological Samples

What Ethical Issues Arise When Using Biological Samples Collected for Another Purpose?

Biological samples collected for clinical care or another study can sometimes be reused for research, but specimens raise issues beyond ordinary data reuse. Consent, identifiability, genetic information, future analyses, sample depletion, governance, and commitments to donors all require attention.

PART 05 · SUBPART 21 · GUIDE 374

Using Existing Records Without Individual Consent

Can Researchers Use Administrative, Clinical, Educational, or Government Records Without Individual Consent?

Researchers can sometimes use existing administrative, clinical, educational, or government records without obtaining individual consent, but there is no general research exemption simply because records already exist. The applicable pathway depends on identifiability, purpose, legal authority, ethics requirements, privacy protections, and the rules governing the records.

PART 05 · SUBPART 21 · GUIDE 373

Who Should Link Identifiable Research Data?

Who Should Be Allowed to Perform Linkage Using Identifiable Data?

Identifiable data used for linkage should be accessible only to authorized people or systems that genuinely need the identifiers to perform an approved function. Separating linkage from analysis can reduce unnecessary exposure while preserving the scientific value of linked data.